Literature DB >> 15101710

The role of cyclic-AMP binding protein (CREB) in leukemia cell proliferation and acute leukemias.

Deepa B Shankar1, Kathleen M Sakamoto.   

Abstract

Leukemia is a result of accumulating genetic alterations. The collaboration of mutations that offer survival and proliferative signals, together with mutations that result in lack of differentiation, is thought to cause a leukemic phenotype. The cyclic-AMP Response Element Binding Protein (CREB) is a transcription factor that is known to be a downstream component of the GM-CSF and IL-3 signaling pathways. We previously showed that CREB is overexpressed in blast cells from patients with acute leukemias. In this paper, we review the role of CREB in hematopoiesis, cell proliferation and acute leukemias.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15101710     DOI: 10.1080/1042819031000151095

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  17 in total

1.  Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation.

Authors:  Lizi Wu; Jingxuan Liu; Ping Gao; Makoto Nakamura; Yang Cao; Huangxuan Shen; James D Griffin
Journal:  EMBO J       Date:  2005-06-16       Impact factor: 11.598

2.  p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk.

Authors:  Valeria Barresi; Giovanni Branca; Maria Caffo; Giovanni Tuccari
Journal:  J Neurooncol       Date:  2015-01-07       Impact factor: 4.130

3.  CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-κB pathways.

Authors:  Bin Li; Lisi Zheng; Jiayi Ye; Chenmin Zhang; Jie Zhou; Qiaojuan Huang; Yanhua Guo; Luqin Wang; Peng Yu; Shurong Liu; Qiao Lin; Yuxia Luo; Hui Zhou; Jianhua Yang; Lianghu Qu
Journal:  Sci China Life Sci       Date:  2022-06-10       Impact factor: 10.372

4.  Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract.

Authors:  Addanki P Kumar; Shylesh Bhaskaran; Manonmani Ganapathy; Katherine Crosby; Michael D Davis; Peter Kochunov; John Schoolfield; I-Tien Yeh; Dean A Troyer; Rita Ghosh
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

5.  Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer.

Authors:  Alfonso Calvo; Carlos Perez-Stable; Victor Segura; Raúl Catena; Elizabeth Guruceaga; Paul Nguewa; David Blanco; Luis Parada; Teresita Reiner; Jeffrey E Green
Journal:  Prostate       Date:  2010-05-01       Impact factor: 4.104

6.  Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein.

Authors:  Sita Aggarwal; Seung-Wook Kim; Seung-Hee Ryu; Wen-Cheng Chung; Ja Seok Koo
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

7.  Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer.

Authors:  Hye-Sook Seo; Diane D Liu; B Nebiyou Bekele; Mi-Kyoung Kim; Katherine Pisters; Scott M Lippman; Ignacio I Wistuba; Ja Seok Koo
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

8.  Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis.

Authors:  Hongxia Sun; Wen-Cheng Chung; Seung-Hee Ryu; Zhenlin Ju; Hai T Tran; Edward Kim; Jonathan M Kurie; Ja Seok Koo
Journal:  Cancer Prev Res (Phila)       Date:  2008-10

9.  COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma.

Authors:  Shumei Song; Sushovan Guha; Kaifeng Liu; Navtej S Buttar; Robert S Bresalier
Journal:  Gut       Date:  2007-06-29       Impact factor: 23.059

10.  Analysis of promoters and CREB/AP-1 binding sites of the human TMEM174 gene.

Authors:  Fen Hu; Yanan Meng; Lixia Gou; Xiujun Zhang
Journal:  Exp Ther Med       Date:  2013-08-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.